Profile
AHPI ABT BSX-PA SYK BSX MDT
Company Name Allied Healthcare Products, Inc. Abbott Laboratories Boston Scientific Corporation Stryker Corporation Boston Scientific Corporation Medtronic plc
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Devices Medical - Devices Medical - Devices Medical - Devices Medical - Devices Medical - Devices
Market Cap - $188.37B $175.45B $139.12B $138.83B $129.15B
Employees 0.15K 114.00K 45.00K 53.00K 53.00K 95.00K
CEO Daniel C. Dunn Robert Ford Michael F. Mahoney Kevin A. Lobo Michael F. Mahoney Geoffrey Straub Martha
Ratings
AHPI ABT BSX-PA SYK BSX MDT
Quant Rating Score 3 2 3 1 3
Quant Rating Neutral Sell Neutral Strong Sell Neutral
Trading
AHPI ABT BSX-PA SYK BSX MDT
Last Close $0.004 $130.03 $122.18 $360.13 $101.76 $96.28
High 52 $0.55 $140.22 $122.18 $403.53 $108.14 $98.43
Low 52 - $111.1 $122.18 $337.28 $88.03 $79.61
Price vs. 52 Week High -99.27 % -7.27 % 0 % -10.76 % -5.9 % -2.18 %
Price vs. 52 Week Low 0 % 17.04 % 0 % 6.77 % 15.6 % 20.94 %
Total Return
AHPI ABT BSX-PA SYK BSX MDT
1 Month Return 0 % 1.16 % 0 % -3.82 % 2.54 % 0.52 %
3 Month Return 0 % -0.18 % 0 % -5.68 % -1.25 % 3.74 %
6 Month Return 0 % -3.54 % 0 % -8.65 % -4.04 % 11.38 %
9 Month Return 0 % -0.12 % 0 % -6.61 % -3.41 % 11.86 %
YTD Return 0 % 14.96 % 0 % 0.02 % 13.93 % 20.53 %
1 Year Return -99.27 % 11.01 % 0 % -7.35 % 12.65 % 13.27 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
AHPI ABT BSX-PA SYK BSX MDT
Dividend Yield Percentage (TTM) - 2.22 % - 0.93 % - 2.81 %
Dividend Paid and Capex Coverage Ration (TTM) - 1.46 % 5.44 % 2.38 % 5.44 % 1.29 %
Dividend Per Share (TTM) - 2.4 % - 3.4 % - 2.83 %
Payout Ratio (TTM) - 61.99 % - 43.09 % - 75.84 %
Growth
AHPI ABT BSX-PA SYK BSX MDT
Asset Growth 11.12 % 11.2 % 12.12 % 7.66 % 12.12 % 1.89 %
Gross Profit Growth -64.45 % 6.43 % 16.26 % 11.89 % 16.26 % 3.58 %
Revenue Growth -25.45 % 4.59 % 17.61 % 10.23 % 17.61 % 3.62 %
Revenue 3 Year -13.81 % -0.18 % 36.16 % 30.69 % 36.16 % 10.52 %
Revenue 5 Year -19.29 % 34.24 % 47.52 % 49.02 % 47.52 % 20.96 %
Revenue 10 Year -36.99 % 80.43 % 104.22 % 132.01 % 104.22 % 41.05 %
EBIT Growth -343.7 % 3.45 % 18.25 % -3.5 % 18.25 % 14.42 %
Net Income Growth -417.77 % 134.18 % 16.38 % -5.43 % 16.38 % 26.82 %
Net Income 3 Yeari Growth Per Share -154.13 % 94.27 % 72.31 % 48.52 % 72.31 % -3.39 %
Net Income 5 Yeari Growth Per Share -156.69 % 271.11 % -62.7 % 41.05 % -62.7 % 1.52 %
Net Income 10 Yeari Growth Per Share -1178.53 % 410.99 % 1502.13 % 477.35 % 1502.13 % 48.51 %
Operating Income Growth -769.74 % 6.06 % 20.82 % 18.22 % 20.82 % 15.77 %
Operating Cash Flow Growth (CFG) -8.25 % 17.86 % 37.24 % 14.31 % 37.24 % 3.79 %
Operating 3 Year CFG -7002.96 % -16.72 % 77.55 % 28.64 % 77.55 % 0.13 %
Operating 5 Year CFG -496.34 % 42.4 % 76.92 % 90.05 % 76.92 % 1.55 %
Operating 10 Year CFG -521.95 % 102.79 % 143.61 % 136.49 % 143.61 % 22.45 %
EPS Growth -419.05 % 132.42 % 16.61 % -5.76 % 16.61 % 31.05 %
EPS Diluted Growth -419.05 % 133.64 % 16.52 % -5.94 % 16.52 % 30.8 %
Book Value Per Share -50.53 % 23.54 % 11.25 % 10.57 % 11.25 % -1.16 %
Share Holder 3 Year Equity Growth Per Share -55.98 % 36.46 % 26.58 % 37.24 % 26.58 % -4.58 %
Share Holder 5 Year Equity Growth Per Share -67.66 % 56.53 % 48.35 % 58.15 % 48.35 % -1.29 %
Share Holder 10 Year Equity Growth Per Share -80.22 % 92.83 % 186.31 % 138.49 % 186.31 % -23.12 %
Dividend Per Share Growth - 8.02 % -100 % 6.63 % -100 % 1.11 %
Dividend 3 Year Growth Per Share - 22.8 % -100 % 26.97 % -100 % 10.78 %
Dividend 5 Year Growth Per Share - 72.53 % - 53.81 % - 29.33 %
Dividend 10 Year Growth Per Share - 148.92 % - 162.12 % - 128.74 %
Debt Growth 18.38 % -3.77 % 17.44 % 4.64 % 17.44 % 13.95 %
Free Cash Flow Growth -5.57 % 25.54 % 55.31 % 11.19 % 55.31 % -0.29 %
Updated On 30 Jun 2022 31 Dec 2024 31 Dec 2024 31 Dec 2024 31 Dec 2024 30 Apr 2025
Profitability
AHPI ABT BSX-PA SYK BSX MDT
Gross Profit Margin TTM 55.51 % 65.05 % 62.63 % 65.05 % 62.27 %
Return on Assets TTM 7.75 % 6.71 % 6.25 % 6.53 % 5.22 %
Return on Equity TTM 13.18 % 12.8 % 13.92 % 12.42 % 9.83 %
Return on Capital Employed TTM 11.56 % 9.22 % 13.47 % 8.97 % 7.63 %
Net Income Per EBT TTM 77.06 % 85.26 % 88.19 % 85.26 % 83.61 %
EBT Per Ebit TTM 105.19 % 97.5 % 62.51 % 97.5 % 91.74 %
EBIT Per Revenue TTM 18.16 % 17.33 % 21.89 % 17.33 % 17.87 %
Cash Flow To Debt Ratio TTM 70.47 % 38.46 % 29.12 % 38.4 % 24.44 %
Receivables Turnover TTM 4.26 6.87 6.69 6.84 5.44
Payables Turnover TTM 4.78 7.03 6.08 6.75 5.08
Inventory Turnover TTM 2.94 2.36 1.7 2.32 2.13
Fixed Asset Turnover TTM 385.33 % 489.63 % 652.95 % 451.15 % 485.18 %
Asset Turnover TTM 52.66 % 46.56 % 51.81 % 45.31 % 38.05 %
Operating Cash Flow Per Share TTM 5.22 3.12 12.64 3.12 5.55
Free Cash Flow Per Share TTM 3.96 2.55 10.65 2.55 4.06
Cash Per Share TTM 442.64 % 36.04 % 874.22 % 86.05 % 649.63 %
Operating Cash Flow Sales Ratio TTM 20.57 % 23.91 % 19.82 % 23.91 % 20.46 %
Free Cash Flow Operating Cash Flow Ratio TTM 75.85 % 81.6 % 84.29 % 81.6 % 73.19 %
Cash Flow Coverage Ratios TTM 70.47 % 38.46 % 29.12 % 38.4 % 24.44 %
Price To Free Cash Flows Ratio TTM 27.23 36.34 34.16 36.77 24.81
Price To Operating Cash Flows Ratio TTM 20.73 29.63 28.79 29.98 18.14
Price Cash Flow Ratio TTM 20.73 29.63 28.79 29.98 18.14
Income Statement (TTM)
AHPI ABT BSX-PA SYK BSX MDT
Revenue $0.03B $44.33B $16.75B $22.6B $16.75B $33.54B
Gross Profit $0B $24.61B $10.27B $13.98B $10.27B $21.91B
Gross Profit Ratio 9.34% 55.51% 61.31% 61.87% 61.31% 65.32%
EBITDA $-0B $11.33B $3.94B $4.94B $3.94B $9.22B
Net Income $-0.01B $6.52B $1.85B $2.99B $1.85B $4.66B
EPS Diluted -1.34 3.72 1.25 7.76 1.25 3.61
Balance Sheet (MRQ)
AHPI ABT BSX-PA SYK BSX MDT
Long Term Debt $0B $13.52B $9.37B $12.57B $9.37B $25.64B
Total Liabilities $0.01B $33.51B $17.39B $22.34B $17.39B $43.42B
Total Equity $0.01B $47.9B $22B $20.63B $22B $48.26B
Total Investments $0B $1.24B $0.56B $0.88B $0.56B $6.75B
Total Debt $0B $15.28B $11.15B $14.12B $11.15B $28.52B
Total Assets $0.02B $81.41B $39.4B $42.97B $39.4B $91.68B
Cash Flow Statement (TTM)
AHPI ABT BSX-PA SYK BSX MDT
Net Income $-0.01B $13.4B $1.85B $2.99B $1.85B $4.69B
Inventory $0B $-0.06B $-0.23B $-0.21B $-0.23B $-0.29B
Dividends Paid $0B $-3.84B $0B $-1.22B $0B $-3.59B
Operating Cash Flow $-0B $8.56B $3.44B $4.24B $3.44B $7.04B
Capital Expenditure $-0B $-2.21B $-0.79B $-0.76B $-0.79B $-1.86B
Related Stocks
Ticker Name Price
ABMD Abiomed, Inc. 381.02
ABT Abbott Laboratories 106.08
ADGM Adagio Medical Holdings, Inc. 1
AEMD Aethlon Medical, Inc. 2.68
AFIB Acutus Medical, Inc. 0.0002
AHCO AdaptHealth Corp. 9.62
ALGN Align Technology, Inc. 164.9
ALUR Allurion Technologies Inc. 1.49
AMIX Autonomix Medical, Inc. Common Stock 0.422
ANIK Anika Therapeutics, Inc. 9.12
AORT Artivion, Inc. 41.36
APEN Apollo Endosurgery, Inc. 10
APYX Apyx Medical Corporation 3.98
ARAY Accuray Incorporated 0.7909
ASXC Asensus Surgical, Inc. 0.3479
ATEC Alphatec Holdings, Inc. 15.265
AVNS Avanos Medical, Inc. 12.87
AVR Anteris Technologies Global Corp. Common Stock 6.35
AXDX Accelerate Diagnostics, Inc. 0.034
AXGN AxoGen, Inc. 34.08
Unlock